Histopathologic Correlation of Residual Mammographic Microcalcifications After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of Surgical Oncology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-014-4113-8PMID 25287438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer

  2013cited by this paper
• Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy

  2013cited by this paper
• Neoadjuvant chemotherapy in the treatment of breast cancer.

  2013cited by this paper
• Surgical management of the breast: breast conservation therapy and mastectomy.

  2013cited by this paper
• Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

  2012cited by this paper
• Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

  2012cited by this paper
• Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.

  2012cited by this paper
• Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.

  2008cited by this paper
• Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant Chemotherapy

  2006cited by this paper
• Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy

  2004cited by this paper
• Breast imaging reporting and data system (BI-RADS).

  2002cited by this paper
• Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

  1998cited by this paper
• Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.

  1996cited by this paper
• Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.

  1996cited by this paper
• The use of mammography in breast preservation in locally advanced breast cancer.

  1996cited by this paper
• Assessment of response to therapy of primary breast cancer by mammography and physical examination

  1995cited by this paper
• Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

  1994cited by this paper
• Mammography in the assessment of response to medical treatment of large primary breast cancer.

  1993cited by this paper
• Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma

  1992cited by this paper
• Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy.

  1988cited by this paper
• Calcifications and the therapeutically irradiated breast.

  1977cited by this paper

• Residual Microcalcifications After Neoadjuvant Chemotherapy: Implications for Surgical Decision-Making—A Systematic Review

  2026cites this paper
• Is It Possible to Accurately Evaluate the Tumor Bed After Neoadjuvant Chemotherapy Using a 14G Tru-Cut Biopsy?

  2025cites this paper
• Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete response.

  2025cites this paper
• Predicting Pathologic Complete Response Using Breast MRI After Completion of Neoadjuvant Chemotherapy in Breast Cancer Patients With Residual Calcifications on Mammography

  2025cites this paper
• Decrease in Calcifications After Neoadjuvant Treatment Predicts Invasive Tumor Response but Not Complete DCIS Eradication: Systematic Review and Meta-Analysis.

  2025cites this paper
• Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review

  2025cites this paper
• Deep learning modeling using mammography images for predicting estrogen receptor status in breast cancer.

  2024cites this paper
• The role and potential of digital breast tomosynthesis in neoadjuvant systemic therapy evaluation for optimising breast cancer management: a pictorial essay

  2024cites this paper
• Differentiation of histological calcification classifications in breast cancer using ultrashort echo time and chemical shift-encoded imaging MRI

  2024cites this paper
• Prediction model for individualized precision surgery in breast cancer patients with complete response on MRI and residual calcifications on mammography after neoadjuvant chemotherapy

  2024influential citation
• Efficacy of Radiodiagnostic and Neural Network Networks in Assessing Breast Cancer Response to Neoadjuvant Treatment of Aggressive Molecular Subtypes

  2024cites this paper
• Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients

  2024cites this paper
• Research Progress of Routine Ultrasound and Ultrasonography in Triple Negative Breast Cancer

  2023cites this paper
• ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update.

  2023cites this paper
• MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?

  2023cites this paper
• Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy for Breast Cancer

  2023cites this paper
• Pathology of neoadjuvant therapy and immunotherapy testing for breast cancer

  2022cites this paper
• Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting

  2022cites this paper
• Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis

  2022influential citation
• Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy

  2022cites this paper
• Breast microcalcifications: Past, present and future (Review)

  2022cites this paper
• Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer

  2021cites this paper
• RETRACTED ARTICLE: Prediction and detection of breast cancer text data using integrated EANN and ESVM techniques

  2021cites this paper
• MRI in the Setting of Neoadjuvant Treatment of Breast Cancer.

  2021cites this paper
• Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives

  2021cites this paper
• Breast Cancer Imaging Pre- and Post-Neoadjuvant Systemic Therapy

  2021cites this paper
• Neoadjuvant Systemic Therapy

  2021cites this paper
• Prediction and detection of breast cancer text data using integrated EANN and ESVM techniques

  2021cites this paper
• Surgery Following Primary Systemic Therapy: How to Increase Breast Conservation Rate

  2020cites this paper
• Therapy Response Imaging in Breast Cancer

  2020cites this paper
• Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer.

  2020cites this paper
• Oncoplastic Breast Surgery Techniques for the General Surgeon

  2020cites this paper
• Locoregional Management After Neoadjuvant Chemotherapy.

  2020cites this paper
• Imaging in Locoregional Management of Breast Cancer

  2020cites this paper
• How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?

  2020cites this paper
• Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

  2020influential citation
• Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy

  2020cites this paper
• Response Assessment and Follow-Up by Imaging in Breast Tumors

  2020cites this paper
• Locoregional Management After Neoadjuvant Chemotherapy

  2020cites this paper
• Complete Breast MRI Response to Neoadjuvant Chemotherapy and Prediction of Pathologic Complete Response.

  2019cites this paper
• Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent

  2019cites this paper
• Step by step: Planning a needle localization procedure.

  2019cites this paper
• Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance.

  2019cites this paper
• Breast Tumor Detection and Classification Using Intravoxel Incoherent Motion Hyperspectral Imaging Techniques

  2019cites this paper
• Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints

  2018cites this paper
• Ist eine Operation der Brust bei Komplettremission nach neoadjuvanter Chemotherapie des Mammakarzinoms notwendig?

  2018cites this paper
• Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.

  2018cites this paper
• Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?

  2018cites this paper
• Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy

  2018cites this paper
• Eliminating Surgery in Early-Stage Breast Cancer: Pipe-Dream or Worthy Consideration in Selected Patients?

  2017cites this paper
• Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy: a Radiologist’s Perspective

  2017cites this paper
• Handling Neoadjuvant Therapy Specimens

  2017cites this paper
• Imaging Evaluation and Chemical Composition Analysis of Calcified

  2017cites this paper
• Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer

  2017cites this paper
• Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012

  2017cites this paper
• Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications.

  2017cites this paper
• Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.

  2017cites this paper
• STATE OF THE ART : Imaging Neoadjuvant Therapy Response in Breast Cancer

  2017cites this paper
• Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer.

  2017cites this paper
• ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer.

  2017cites this paper
• Imaging Neoadjuvant Therapy Response in Breast Cancer.

  2017cites this paper
• Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?

  2017cites this paper
• Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor

  2017cites this paper
• Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size

  2016cites this paper
• Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer

  2016cites this paper
• Does change in microcalcifications with neoadjuvant treatment correlate with pathological tumour response?

  2016cites this paper
• Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer

  2016influential citation
• Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

  2016cites this paper